secwatch / observer
8-K filed September 7, 2023, 7:59 PM ET ticker HCIL CIK 0001086303
M&A confidence high sentiment neutral materiality 0.90

Hongchang International Co., Ltd (HCIL): M&A transaction — Heyu Biological Technology acquires Hongchang Group in reverse merger, exits prior cancer therapy business

Hongchang International Co., Ltd

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Hongchang International Co., Ltd completed an acquisition involving Zengqiang Investment Limited and Hong Jin Investment Limited for 353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited (closed 2023-09-04).

Action
acquisition
Counterparty
Zengqiang Investment Limited and Hong Jin Investment Limited
Consideration
353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited
Closing
2023-09-04
Exact text from the filing
In accordance with the terms of the Share Exchange Agreement, on September 4, 2023, the Selling Shareholders transferred 100 shares of Hongchang BVI, constituting one hundred percent (100%) of the issued and outstanding share capital of Hongchang BVI, to our Company in exchange for the issuance of 353,322,843 shares of our common stock to Zengqiang Investment Limited, and 62,259,532 shares of our common stock to Hong Jin Investment Limited.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Hongchang International Co., Ltd completed a disposition involving Ban Siong Ang (closed 2023-09-04).

Action
disposition
Counterparty
Ban Siong Ang
Closing
2023-09-04
Exact text from the filing
The Share Disposal was consummated on September 4, 2023.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Hongchang International Co., Ltd entered into Share Exchange Agreement with Zengqiang Investment Limited and Hong Jin Investment Limited valued at an aggregate of 415,582,375 new shares of our Company’s common stock (effective 2023-08-21).

Action
entry
Agreement
merger
Counterparty
Zengqiang Investment Limited and Hong Jin Investment Limited
Value
an aggregate of 415,582,375 new shares of our Company’s common stock
Effective
2023-08-21
Exact text from the filing
On August 21, 2023, our Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Hongchang BVI, a business company incorporated in the BVI, and Hongchang BVI’s shareholders, Zengqiang Investment Limited, a business company incorporated in the BVI, and Hong Jin Investment Limited, a business company incorporated in the BVI (the “Selling Shareholders” and each a “Selling Shareholder”), in relation to the acquisition of Hongchang BVI by our Company (the “Hongchang Acquisition”).
View on SEC.gov

28 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Hongchang International Co., Ltd filing history →

Source: SEC EDGAR
accession 0001213900-23-074978
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.